stars 1 stars 2 stars 3

Oncorena is aiming to save human lives by transforming a natural substance into a breakthrough therapy treatment for advanced kidney cancer. We have completed all preclinical studies and are moving into early-stage clinical development. The objective is to confirm the powerful anti-tumor activity of our drug candidate - based on the natural substance orellanine - in advanced kidney cancer patients. Oncorena AB is headquartered in Lund, Sweden.

Oncorena AB Questions

The Oncorena AB annual revenue was $811000 in 2026.

Susanna Dahlgren is the COO of Oncorena AB.

6 people are employed at Oncorena AB.

Oncorena AB is based in Lund, Skane.

The NAICS codes for Oncorena AB are [32541, 32, 3254, 325].

The SIC codes for Oncorena AB are [283, 28].

Top Oncorena AB Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users